Shang-Ju Wu

4PUBLICATIONS
21CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursMedical biotechnology not elsewhere classified
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Apr 22, 2026
Rituximab, Acalabrutinib, and Durvalumab for Primary Central Nervous System Lymphoma: A Single-Arm, Phase Ib, Multicenter Study.

|Jan 29, 2026
Second primary malignancies in Asian chronic lymphocytic leukaemia patients: A Taiwan Cancer Registry Study.

Yi-Wei Lee, Chun-Ju Chiang, Ying-Chu Lin

|Apr 15, 2025
The ENHANCE-3 study: venetoclax and azacitidine plus magrolimab or placebo for untreated AML unfit for intensive therapy.

Naval Daver, Paresh Vyas, Gerwin Huls

|Aug 30, 2022
Functional association of NR4A3 downregulation with impaired differentiation in myeloid leukemogenesis.

Shih-Chiang Lin, Chi-Yuan Yao, Cheng-An Hsu

Pageof 1

Frequent Collaborators

1 joint publications

Naval G Daver

1 joint publications

Paresh Vyas

1 joint publications

Hartmut Döhner

1 joint publications

Sebastien Maury